The predictive value of the acute effect of montelukast on an exercise challenge test for the outcome of longterm treatment with montelukast.
Phase of Trial: Phase IV
Latest Information Update: 14 Aug 2014
At a glance
- Drugs Montelukast (Primary)
- Indications Allergic asthma; Bronchoconstriction; Exercise-induced asthma
- Focus Therapeutic Use
- Acronyms SD-MLK
- 13 Jul 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record
- 28 Mar 2012 Actual initiaiton date 22 Apr 2010 adde as reported by European Clinical Trials Database.
- 28 Mar 2012 Status changed from planning to recruiting as reported by European Clinical Trials Database.